We have updated our Privacy Policy to comply with the new requirements under the EU General Data Protection Regulation (GDPR), effective May 25, 2018.
By clicking "Complete Login", you agree with Practice Point Communication's Privacy Policy and Terms of Use.
This activity will inform participants about the complex pathophysiology of NF1-PN and how an understanding of molecular pathways has led to the development of MEK inhibitors. The key published and ongoing clinical evidence on the utility of approved and emerging therapies for NF1-PN will be detailed to provide a strong foundation for clinical decision-making. An in-depth guide to recognize and diagnose patients with NF1-PN will also be discussed in this module to facilitate an accurate and timely diagnosis. Overall, this presentation will ensure that participants appreciate the need to recognize and treat NF1-PN among pediatric patients.
AMA/ABS/ANCC- Video Lecture Library
Launch/Release Date: October 2, 2025 Activity Expiration Date: September 30, 2026